RI
Rezolute Inc
🇺🇸XNAS.RZLTUnited StatesHealthcare
$3.98USDdown -0.18 (-4.33%)ClosedEnd of day8:27 AM
Price$3.98-0.18 (-4.33%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US76200L3096
- CUSIP
- 76200L309
Company
- Employees
- 68
- Headquarters
- Redwood City, United States
- Website
- https://www.rezolutebio.com
- CEO
- Mr. Nevan Charles Elam J.D.
Market
- Shares outstanding
- 96.3M
- Market cap
- $383.24M
Highlights
- Market cap
- $383.24M
- EPS LTM
- -$0.85calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -4.70calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $46K-20.69%down year on year
- Net income
- -$81.49M-11.63%down year on year
- Gross margin
- 32.61%-32.45%down year on year
- Free cash flow
- -$73.48M-12.01%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.